FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367172471> ?p ?o ?g. }

• W4367172471 abstract "Abstract Background Clozapine is a second-generation antipsychotic which is known to have superior efficacy as compared to other antipsychotics. It is particularly used in treatment-resistant schizophrenia (10–30%). However, its use is limited due to the serious side effect of inducing seizures which can occur at all doses. The purpose of our study was to analyse patients taking clozapine for any electroencephalographic (EEG) abnormalities. We undertook a cross-sectional study on 107 patients with a different diagnosis taking clozapine who visited the outdoor treatment facility of a tertiary care psychiatric diseases hospital in Kashmir. A 32-channel digital EEG was obtained and evaluated visually for any abnormalities in these patients. The data was tabulated and analysed using SPSS 23.0. Results EEG abnormalities were reported in 60.75% of patients receiving clozapine out of which slow waves and epileptiform activities were present in 48.60% and 30.84% of patients, respectively. Background slowing was often in the delta and theta ranges. Our study showed that there was a statistically significant relationship between the dose of clozapine and EEG abnormalities. Clinical seizure occurred in only one patient receiving clozapine 450 mg/day and was a smoker who had recently stopped smoking. Conclusions EEG abnormalities occur frequently in clozapine-treated patients specifically those taking higher doses of clozapine. This calls for utilising EEG as a useful clinical investigation in these patients along with clinical monitoring of seizures especially in those taking higher doses of clozapine in order to hint towards early signs of clozapine toxicity. Caution needs to be taken in patients who are smokers and show a pattern of change in their smoking habits. Moreover, EEG abnormalities though frequently associated with clozapine are not reliable predictors of seizures. Therefore, anticonvulsants may not be routinely indicated in patients on clozapine even in the presence of epileptiform discharges." @default.
• W4367172471 created "2023-04-28" @default.
• W4367172471 creator A5045241264 @default.
• W4367172471 creator A5048245074 @default.
• W4367172471 creator A5068402189 @default.
• W4367172471 date "2023-04-28" @default.
• W4367172471 modified "2023-10-14" @default.
• W4367172471 title "Prevalence and pattern of electroencephalographic changes associated with clozapine treatment: a cross-sectional study" @default.
• W4367172471 cites W1736245636 @default.
• W4367172471 cites W2027299461 @default.
• W4367172471 cites W2058883798 @default.
• W4367172471 cites W2059230444 @default.
• W4367172471 cites W2072742822 @default.
• W4367172471 cites W2081085960 @default.
• W4367172471 cites W2085719837 @default.
• W4367172471 cites W2106365121 @default.
• W4367172471 cites W2123186700 @default.
• W4367172471 cites W2130847692 @default.
• W4367172471 cites W2144019094 @default.
• W4367172471 cites W2162905199 @default.
• W4367172471 cites W2172296704 @default.
• W4367172471 cites W2320362137 @default.
• W4367172471 cites W2377169197 @default.
• W4367172471 cites W2418302419 @default.
• W4367172471 cites W2608792222 @default.
• W4367172471 cites W2928636018 @default.
• W4367172471 cites W2938139043 @default.
• W4367172471 cites W3000391694 @default.
• W4367172471 cites W3026480754 @default.
• W4367172471 cites W3027467172 @default.
• W4367172471 cites W36453299 @default.
• W4367172471 cites W50842702 @default.
• W4367172471 doi "https://doi.org/10.1186/s43045-023-00311-7" @default.
• W4367172471 hasPublicationYear "2023" @default.
• W4367172471 type Work @default.
• W4367172471 citedByCount "0" @default.
• W4367172471 crossrefType "journal-article" @default.
• W4367172471 hasAuthorship W4367172471A5045241264 @default.
• W4367172471 hasAuthorship W4367172471A5048245074 @default.
• W4367172471 hasAuthorship W4367172471A5068402189 @default.
• W4367172471 hasBestOaLocation W43671724711 @default.
• W4367172471 hasConcept C118552586 @default.
• W4367172471 hasConcept C142052008 @default.
• W4367172471 hasConcept C142724271 @default.
• W4367172471 hasConcept C187212893 @default.
• W4367172471 hasConcept C2776412080 @default.
• W4367172471 hasConcept C2780494398 @default.
• W4367172471 hasConcept C2780864610 @default.
• W4367172471 hasConcept C42219234 @default.
• W4367172471 hasConcept C522805319 @default.
• W4367172471 hasConcept C71924100 @default.
• W4367172471 hasConceptScore W4367172471C118552586 @default.
• W4367172471 hasConceptScore W4367172471C142052008 @default.
• W4367172471 hasConceptScore W4367172471C142724271 @default.
• W4367172471 hasConceptScore W4367172471C187212893 @default.
• W4367172471 hasConceptScore W4367172471C2776412080 @default.
• W4367172471 hasConceptScore W4367172471C2780494398 @default.
• W4367172471 hasConceptScore W4367172471C2780864610 @default.
• W4367172471 hasConceptScore W4367172471C42219234 @default.
• W4367172471 hasConceptScore W4367172471C522805319 @default.
• W4367172471 hasConceptScore W4367172471C71924100 @default.
• W4367172471 hasIssue "1" @default.
• W4367172471 hasLocation W43671724711 @default.
• W4367172471 hasOpenAccess W4367172471 @default.
• W4367172471 hasPrimaryLocation W43671724711 @default.
• W4367172471 hasRelatedWork W1970998752 @default.
• W4367172471 hasRelatedWork W1982539986 @default.
• W4367172471 hasRelatedWork W2003171974 @default.
• W4367172471 hasRelatedWork W2118970553 @default.
• W4367172471 hasRelatedWork W2144557577 @default.
• W4367172471 hasRelatedWork W2939945051 @default.
• W4367172471 hasRelatedWork W3093992020 @default.
• W4367172471 hasRelatedWork W3118631796 @default.
• W4367172471 hasRelatedWork W3128346550 @default.
• W4367172471 hasRelatedWork W4235576420 @default.
• W4367172471 hasVolume "30" @default.
• W4367172471 isParatext "false" @default.
• W4367172471 isRetracted "false" @default.
• W4367172471 workType "article" @default.